Literature DB >> 14672525

Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.

Hisashi Saji1, Haruhiko Nakamura, Idiris Awut, Norihito Kawasaki, Masaru Hagiwara, Akihiko Ogata, Makoto Hosaka, Takamoto Saijo, Yasubumi Kato, Harubumi Kato.   

Abstract

Recent studies have evaluated the cytokine network involved in the local immune response to tumors. In addition to infiltrating inflammatory cells, tumors also produce cytokines and growth factors that may alter tumor growth and tumor immunogenicity. Ninety-one samples of NSCLC were used in this study. We measured the expression of VEGF, TNF-alpha, TGF-beta, IL-6, IL-8, IL-12, INF-gamma, and MCP-1 in NSCLC tissues, by ELISA. The expression of IL-6 and IL-8 were significantly higher in squamous cell carcinoma than in adenocarcinoma (p=0.016 and p<0.001, respectively). The expression of TGF-beta, MCP-1 and IL-8 were significantly higher in pulmonary metastasis positive than negative cases (p=0.002, p=0.001, and p=0.008, respectively). In multivariate logistic regression analysis, the expression of TGF-beta was an independent risk factor for the occurrence of pulmonary metastasis (p=0.008, 95% CI=1.002-1.011). We confirmed that tumor infiltrating stromal cells were major sources of TGF-beta by immunohistochemical analysis. The expression of VEGF and IL-8 were significantly higher in cases with central necrosis (p=0.006 and p=0.011, respectively). We speculated that TGF-beta expression in tumor infiltrating stromal cells may regulate the occurrence of spontaneous pulmonary metastasis in NSCLC. (Ann Thorac Cardiovasc Surg 2003; 9: 295-300)

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14672525

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  19 in total

1.  Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line.

Authors:  S Salem; T Harris; J S L Mok; M Y S Li; C R Keenan; M J Schuliga; A G Stewart
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 2.  Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation.

Authors:  C-Q Zhu; W Shih; C-H Ling; M-S Tsao
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways.

Authors:  Lee A Borthwick; Aaron Gardner; Anthony De Soyza; Derek A Mann; Andrew J Fisher
Journal:  Cancer Microenviron       Date:  2011-07-27

4.  Perspective on the treatment of non-small cell lung cancer in the context of potential SARS-CoV-2 infection during the pandemic.

Authors:  George Theodoropoulos; Katerina Albanis; Medhi Wangpaichitr
Journal:  J Curr Sci Technol       Date:  2021-01

5.  TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells.

Authors:  Sarah S Donatelli; Jun-Min Zhou; Danielle L Gilvary; Erika A Eksioglu; Xianghong Chen; W Douglas Cress; Eric B Haura; Matthew B Schabath; Domenico Coppola; Sheng Wei; Julie Y Djeu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

6.  Decorin inhibits the proliferation of HepG2 cells by elevating the expression of transforming growth factor-β receptor II.

Authors:  Yanfeng Liu; Xuesong Wang; Zhaohui Wang; Wenbo Ju; Dawei Wang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

Review 7.  In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids.

Authors:  Mahesh Devarasetty; Steven D Forsythe; Ethan Shelkey; Shay Soker
Journal:  Tissue Eng Regen Med       Date:  2020-05-12       Impact factor: 4.169

Review 8.  Tgf-beta signaling pathway in lung adenocarcinoma invasion.

Authors:  Rebecca L Toonkel; Alain C Borczuk; Charles A Powell
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

9.  Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma.

Authors:  Sergey Malchenko; Elisabeth A Seftor; Yuri Nikolsky; Susan L Hasegawa; Sean Kuo; Jeff W Stevens; Stas Poyarkov; Tatiana Nikolskaya; Tamara Kucaba; Min Wang; Hakim Abdulkawy; Thomas Casavant; Jose Morcuende; Joseph Buckwalter; Raymond Hohl; Barry Deyoung; Kemp Kernstine; Maria de Fatima Bonaldo; Mary J C Hendrix; Marcelo B Soares; Vera Maria F C Soares
Journal:  Sarcoma       Date:  2012-02-16

10.  TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.

Authors:  Xianglin Yuan; Qingyi Wei; Ritsuko Komaki; Zhensheng Liu; Ju Yang; Susan L Tucker; Ting Xu; John V Heymach; Charles Lu; James D Cox; Zhongxing Liao
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.